التفاصيل البيبلوغرافية
العنوان:
Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358
المؤلفون:
Ibrahima Soumaoro , Ricardo Zwirtes , Ragini R. Kudchadkar , Shailender Bhatia , Shrujal S. Baxi , Janis M. Taube , Tian Chen , Céleste Lebbé , Robert L. Ferris , Asim Amin , William H. Sharfman , Jean-Pierre Delord , Christine H. Chung , Z. Alexander Cao , Suzanne L. Topalian , Michi M. Shinohara , Uwe M. Martens , Julie E. Stein , Paul Nghiem
المصدر:
Journal of Clinical Oncology . 36:9505-9505
بيانات النشر:
American Society of Clinical Oncology (ASCO), 2018.
سنة النشر:
2018
مصطلحات موضوعية:
Cancer Research , integumentary system , biology , business.industry , Merkel cell carcinoma , medicine.medical_treatment , virus diseases , food and beverages , Merkel cell polyomavirus , biology.organism_classification , medicine.disease , 030207 dermatology & venereal diseases , 03 medical and health sciences , 0302 clinical medicine , Oncology , 030220 oncology & carcinogenesis , Cancer research , Medicine , In patient , Skin cancer , Nivolumab , business , Neoadjuvant therapy
الوصف:
9505Background: MCC is a rare, aggressive skin cancer commonly associated with the oncogenic Merkel cell polyomavirus (MCPyV). The PD-1/PD-L1 immunosuppressive pathway is often upregulated in MCC, ...
تدمد:
1527-7755 0732-183X
الوصول الحر:
https://explore.openaire.eu/search/publication?articleId=doi_________::f70ad60763a8f63cab9eb4570130ba75Test https://doi.org/10.1200/jco.2018.36.15_suppl.9505Test
رقم الانضمام:
edsair.doi...........f70ad60763a8f63cab9eb4570130ba75
قاعدة البيانات:
OpenAIRE